Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05915975 · ClinicalTrials.gov registry record · NA

Integrated Behavioral Healthcare for Youth With Type 1 Diabetes

A NA study of Diabetes Mellitus, Type 1, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT05915975: Completed NA study of Diabetes Mellitus, Type 1, sponsored by University of Miami.

NCT05915975 is a NA study of Diabetes Mellitus, Type 1 that has completed, run by University of Miami. The registered enrollment target is 9 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05915975, a NA study of Diabetes Mellitus, Type 1, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand how behavioral health care that is coordinated with diabetes medical care compared with behavioral care that is provided in the community (and therefore not coordinated with diabetes medical care).

Primary Outcome

Will be measured by glycosylated hemoglobin A1c

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Care Coordinated with Medical Care Intervention
  • BEHAVIORAL Behavioral Care Not Coordinated with Medical Care Intervention

Study Locations (1)

Florida

  • Univeristy of Miami - Miami

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-11-07
Est. Completion 2024-09-30
Phase NA
University of Miami

721 total trials

What the finished NCT05915975 record still lists

NCT05915975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Care Coordinated with Medical Care Intervention is the first listed.

NCT05915975 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05915975 about?

NCT05915975 is a clinical study titled "Integrated Behavioral Healthcare for Youth With Type 1 Diabetes". The purpose of this study is to understand how behavioral health care that is coordinated with diabetes medical care compared with behavioral care that is provided in the community (and therefore not coordinated with diabetes medical care).

What is the current status of trial NCT05915975?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-11-07. Estimated completion is 2024-09-30.

What conditions does trial NCT05915975 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

What interventions are being tested in trial NCT05915975?

The interventions under investigation include: Behavioral Care Coordinated with Medical Care Intervention (BEHAVIORAL), Behavioral Care Not Coordinated with Medical Care Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05915975?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05915975 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05915975's enrollment target sits among peer trials

9 115th of 118 higher than 3 of 118 other Diabetes Mellitus, Type 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05915975, the US trial registry maintained by the National Library of Medicine. NCT05915975 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.